search

ABVC Biopharma Inc (ABVC)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
ABVC BioPharma closes $3.39M private placement of convertible notes
Nov 2, 2026

ABVC BioPharma closes $3.39M private placement of convertible notes

ABVC BioPharma, Inc. (NASDAQ: ABVC) has successfully closed a private placement of original issue discount senior convertible promissory notes, raising approximately $3.39 million in gross proceeds. The notes have an aggregate principal amount of $4,106,060, a 17.5% original issue discount, and mature on June 30, 2027, converting into common stock at 85% of the average volume-weighted average price. The company intends to use the net proceeds for general working capital, funding subsidiaries, and a $625,000 settlement payment to Lind Global Fund II LP.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral